Published in 1994: This text focuses on the determination of bioequivalence between formulations that are pharmaceutically equivalent and manufactured using acceptable chemistry, manufacturing and controls and in accordance with Good Manufacturing Practices.
"synopsis" may belong to another edition of this title.
Andre J. Jackson Ph.D., is a reviewer at the U.S. Food and Drug Administration Office of Generic Drugs in the Center for Drug Evaluation and Research.
"About this title" may belong to another edition of this title.